ANI Pharmaceuticals Inc (ANIP)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 51,333 | -32,413 | -26,347 | 111,827 | 143,393 |
| Revenue | US$ in thousands | 454,334 | 287,962 | 202,731 | 198,984 | 206,547 |
| Gross profit margin | 11.30% | -11.26% | -13.00% | 56.20% | 69.42% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $51,333K ÷ $454,334K
= 11.30%
The gross profit margin of ANI Pharmaceuticals Inc has shown fluctuations over the past five years. In Dec 2023, the gross profit margin improved to 62.71% compared to the previous year's 56.13%. This indicates that the company was able to increase its profitability on sales after accounting for the cost of goods sold. However, it is important to note that in Dec 2021 and Dec 2022, the gross profit margin was lower at 53.45% and 56.13%, respectively.
The highest gross profit margin was recorded in Dec 2019 at 69.42%, suggesting a more profitable performance in that year compared to the subsequent years. Overall, the trend in the gross profit margin of ANI Pharmaceuticals Inc demonstrates some variability, and it is essential for the company to sustain or improve this margin to ensure consistent profitability on its core business operations.
Peer comparison
Dec 31, 2023